Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rimplejeet Kaur

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Clinical Pharmacology|April 19, 2016
Endocannabinoid System: A Multi-Facet Therapeutic TargetRimplejeet Kaur, Sneha R Ambwani, Surjit Singh
Indian Journal of Pharmacology|December 30, 2016
Knowledge, awareness and practice of ethics among doctors in tertiary care hospitalSurjit Singh, Pramod Kumar Sharma, Bharti Bhandari, et al.
Journal of Family Medicine and Primary Care|September 27, 2021
A comprehensive insight on the COVID-19 vaccine candidatesAnu Sharma, Ravi Prakash Sharma, Rimplejeet Kaur, et al.
Journal of Pharmacy & Bioallied Sciences|October 26, 2020
Relationship between clinical trials and disease burden of India: A cross-sectional studyRimplejeet Kaur, Jaykaran Charan, Tea Reljic, et al.
Current Clinical Pharmacology|August 12, 2017
Monoclonal Antibodies: A ReviewSurjit Singh, Nitish K Kumar, Pradeep Dwiwedi, et al.
Indian Journal of Clinical Biochemistry : IJCB|August 25, 2020
Snapshot of COVID-19 Related Clinical Trials in IndiaJaykaran Charan, Rimplejeet Kaur, Pankaj Bhardwaj, et al.
Journal of Family Medicine and Primary Care|November 20, 2019
Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysisJaykaran Charan, Nitish Tank, Tea Reljic, et al.
Cureus|February 24, 2022
Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 VaccinesSiddhartha Dutta, Rimplejeet Kaur, Jaykaran Charan, et al.
Indian Journal of Clinical Biochemistry : IJCB|November 9, 2020
Use of Complementary and Alternative Medicine (CAM) and Home Remedies by COVID-19 Patients: A Telephonic SurveyJaykaran Charan, Pankaj Bhardwaj, Siddhartha Dutta, et al.
Expert Opinion on Drug Safety|June 24, 2021
Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO databaseJaykaran Charan, Siddhartha Dutta, Rimplejeet Kaur, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Clinical Pharmacology|April 19, 2016
Endocannabinoid System: A Multi-Facet Therapeutic TargetRimplejeet Kaur, Sneha R Ambwani, Surjit Singh
Indian Journal of Pharmacology|December 30, 2016
Knowledge, awareness and practice of ethics among doctors in tertiary care hospitalSurjit Singh, Pramod Kumar Sharma, Bharti Bhandari, et al.
Journal of Family Medicine and Primary Care|September 27, 2021
A comprehensive insight on the COVID-19 vaccine candidatesAnu Sharma, Ravi Prakash Sharma, Rimplejeet Kaur, et al.
Journal of Pharmacy & Bioallied Sciences|October 26, 2020
Relationship between clinical trials and disease burden of India: A cross-sectional studyRimplejeet Kaur, Jaykaran Charan, Tea Reljic, et al.
Current Clinical Pharmacology|August 12, 2017
Monoclonal Antibodies: A ReviewSurjit Singh, Nitish K Kumar, Pradeep Dwiwedi, et al.
Indian Journal of Clinical Biochemistry : IJCB|August 25, 2020
Snapshot of COVID-19 Related Clinical Trials in IndiaJaykaran Charan, Rimplejeet Kaur, Pankaj Bhardwaj, et al.
Journal of Family Medicine and Primary Care|November 20, 2019
Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysisJaykaran Charan, Nitish Tank, Tea Reljic, et al.
Cureus|February 24, 2022
Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 VaccinesSiddhartha Dutta, Rimplejeet Kaur, Jaykaran Charan, et al.
Indian Journal of Clinical Biochemistry : IJCB|November 9, 2020
Use of Complementary and Alternative Medicine (CAM) and Home Remedies by COVID-19 Patients: A Telephonic SurveyJaykaran Charan, Pankaj Bhardwaj, Siddhartha Dutta, et al.
Expert Opinion on Drug Safety|June 24, 2021
Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO databaseJaykaran Charan, Siddhartha Dutta, Rimplejeet Kaur, et al.
Pageof 1